<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)</article-title>
</title-group>
